首页 > 市场调查报告书 > 製药

基因治疗学和RNAi

市场调查报告书

商品编码

1452798

全球 RNA 分析市场规模、份额、成长分析（按技术、按产品、按应用）- 产业预测 (2024-2031)

Global RNA Analysis Market Size, Share, Growth Analysis, By Technology(Real Time-PCR Technology, Microarray Technology), By Product, By Application - Industry Forecast 2024-2031

出版日期: 2024年03月08日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球RNA分析市场规模为155亿美元，从2023年的161.2亿美元成长到2031年的220.6亿美元，复合年增长率预计为4.00%。

由于越来越多的人采用矿物质补充品来治疗大部分人群中普遍存在的慢性疾病，例如癌症、骨质疏鬆症和贫血症，这个市场正在蓬勃发展。大型製药公司积极参与社会宣传活动，以促进更健康的生活方式和补充品的使用。例如，2023 年 2 月，Torrent Pharmaceuticals Ltd 推出了#BeShelcalStrong，这是一项电视宣传活动，旨在提高人们对缺乏钙及其对日常生活影响的认识。随着久坐生活方式和不健康饮食的增加，越来越多的人面临营养缺乏，导致疲劳、骨骼脆弱和免疫系统减弱等问题。政府促进健康生活方式的措施进一步促进了市场成长。主要参与者专注于创新产品开发和探索异国风成分，而植物来源产品的流行提供了进一步的成长机会。在 COVID-19 大流行期间，对矿物质补充食品的需求增加，因为研究表明该病毒对矿物质缺乏症的影响尤其严重。儘管有这些积极的趋势，但市场仍面临仿冒品销售的挑战，因为经济危机和政治衝突扰乱了供应链并导致更便宜的本地生产商品的扩散。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

Thermo Fisher Scientific Inc.（USA）
Illumina, Inc.（USA）
Agilent Technologies, Inc.（USA）
Qiagen AG（Germany）
PerkinElmer, Inc.（USA）
Eurofins Scientific SE（Luxembourg）
Genewiz（a Brooks Life Sciences Company）（USA）
Bio-Rad Laboratories, Inc.（USA）
Merck KGaA（Germany）
Promega Corporation（USA）
Fluidigm Corporation（USA）
Oxford Nanopore Technologies Ltd.（United Kingdom）
Takara Bio Inc.（Japan）
Zymo Research Corporation（USA）
BGI Group（China）
NuGEN Technologies, Inc.（USA）
Lexogen GmbH（Austria）
Pacific Biosciences of California, Inc.（USA）
Roche Diagnostics（Switzerland）
Bio-Techne Corporation（USA）

简介目录

Product Code: SQMIG35H2192

Global RNA Analysis Market size was valued at USD 15.5 billion in 2022 and is poised to grow from USD 16.12 billion in 2023 to USD 22.06 billion by 2031, growing at a CAGR of 4.00% during the forecast period (2024-2031).

The market is experiencing a surge driven by the growing adoption of mineral supplements to manage chronic conditions prevalent in a significant portion of the population, such as cancer, osteoporosis, anemia, and osteoporosis. Major pharmaceutical companies are actively engaging in social campaigns to promote healthier lifestyles and supplement usage. For instance, in February 2023, Torrent Pharmaceuticals Ltd launched the TV campaign #BeShelcalStrong, aiming to raise awareness about calcium deficiency and its impact on daily life. The rise in sedentary lifestyles and unhealthy diets has resulted in more people facing nutritional deficiencies, leading to issues like fatigue, weak bones, and compromised immune systems. Government initiatives promoting healthier lifestyles further contribute to market growth. Key players are focusing on innovative product development and exploring exotic ingredients, while the popularity of plant-based products presents additional growth opportunities. Amid the COVID-19 pandemic, mineral supplements witnessed increased demand, as research indicated the virus disproportionately affected individuals with mineral deficiencies. Despite this positive trend, the market faces challenges from counterfeit product sales, driven by economic crises and political conflicts disrupting the supply chain and leading to the proliferation of locally produced, inexpensive items.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global RNA Analysis Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global RNA Analysis Market Segmental Analysis

The global RNA analysis market is segmented on the basis of technology, product, application, end - use, region. By technology, the market is segmented real time-pcr (QPCR) technology, microarray technology, sequencing technology, and others. By product, the market is segmented into instruments, kits & reagents, cho media mirna & sirna, reverse transcriptases & rt-pcr, rna interference, rna extraction & purification, others, services. By application, the market is segmented into construction of rna expression atlas, infectious diseases & pathogenesis, epigenetics, alternative rna splicing, rna structure & molecular dynamics, development & delivery of rna therapeutics, others. By end - use, the market is segmented into government institutes & academic centers, contract research organizations (CROs), pharmaceutical & biotechnology companies, hospitals & clinics. By region, the market is segmented into North America, Europe, Latin America, Asia- Pacific, Middle East and Africa.

Drivers of the Global RNA Analysis Market

The pharmaceutical and biotech industries extensively depend on RNA analysis for the advancement of targeted therapies, personalized medicine, and novel drug candidates. This heightened reliance has generated significant demand for RNA analysis techniques within these sectors.

Restraints in the Global RNA Analysis Market

Analyzing RNA sequencing data requires intricate bioinformatics expertise and resources, posing a potential barrier to its widespread adoption in certain environments. The complexity of the process may limit accessibility and implementation in settings where specialized skills and dedicated resources may be scarce.

Market Trends of the Global RNA Analysis Market

The progress in long-read sequencing technologies has empowered the precise sequencing of entire RNA molecules, thereby advancing our comprehension of alternative splicing, isoforms, and intricate gene structures.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global RNA Analysis Market by Technology

Market Overview
Real Time-PCR (qPCR) Technology
Microarray Technology
Sequencing Technology
Others

Global RNA Analysis Market by Product

Market Overview
Instruments
Kits & Reagents
CHO Media miRNA & siRNA
Reverse Transcriptases & RT-PCR
RNA Extraction & Purification
RNA Interference
Others
Services

Global RNA Analysis Market by Application

Market Overview
Construction of RNA Expression Atlas
Epigenetics
Infectious Diseases & Pathogenesis
Alternative RNA Splicing
RNA Structure & Molecular Dynamics
Development & Delivery of RNA Therapeutics
Others

Global RNA Analysis Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific SE (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genewiz (a Brooks Life Sciences Company) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies Ltd. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Zymo Research Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BGI Group (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
NuGEN Technologies, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lexogen GmbH (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pacific Biosciences of California, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments